The American Society of Clinical Oncology honors Baptist Cancer Center’s Osarogiagbon
MEMPHIS, Tenn., Aug. 7, 2024 – Dr. Raymond Osarogiagbon, chief scientist for Baptist Memorial Health Care and director of the Multidisciplinary Thoracic Oncology Program and the Thoracic Oncology Research Group at Baptist Cancer Center, has been named a fellow of the American Society of Clinical Oncology.
FASCO recognizes ASCO members for their extraordinary volunteer service, significant contributions to the specialty of oncology and extraordinary dedication to improving outcomes for cancer patients. Osarogiagbon was one of 50 members worldwide to earn the FASCO designation in 2024.
“I am delighted to be honored as a fellow of the American Society of Clinical Oncology,” said Dr. Osarogiagbon. “To work alongside other scientists and physicians through organizations, such as ASCO, to collectively advance cancer science and precision oncology to benefit patients is a true privilege. This honor is also a testament to the impressive outcomes of the Mid-South Miracle and the other innovative work we’re doing at Baptist.”
Osarogiagbon has been a member of ASCO since 2002. His roles with ASCO have included serving as chair of the ASCO Research Committee from 2023–24 and chair of the 2024 ASCO Quality Symposium. In addition to ASCO, Osarogiagbon has served in leadership positions for several other national and international professional organizations, including the Fleischner Society, National Lung Cancer Roundtable, National Cancer Institute’s board of scientific advisors and the International Association for the Study of Lung Cancer Staging and Prognostic Factors Group chair-elect. He has also served as board chair of the Hope Foundation for Cancer Research.
At Baptist, Dr. Osarogiagbon spearheads the Mid-South Miracle, a multifaceted initiative comprising seven components to reduce lung cancer deaths in the Mid-South 25% by 2030. A community oncologist, Osarogiagbon serves as primary investigator for the Baptist Memorial Health Care/Mid-South Minority Underserved NCI Community Oncology Research Program. He is also a research professor at Vanderbilt University.
The FASCO recognition, which originated in 2007 as the ASCO Statesman Award, has been conferred on 399 individuals up to 2023. Founded in 1964, ASCO has more than 45,000 active members — oncology professionals who care for people living with cancer. Once conferred, the FASCO recognition is for life.
Baptist Cancer Center provides world-class cancer care close to home throughout Baptist Memorial Health Care’s tristate service area of Arkansas, Mississippi and Tennessee. Taking an interdisciplinary approach to patient care, Baptist Cancer Center offers treatment, research, support services, community education and the area's first genetic counseling and testing program for cancer. Baptist Cancer Center also has the Mid-South's first adult myelosuppression unit and is one of only 45 National Cancer Institute Community Oncology Research Program institutions, as well as one of 13 institutions distinguished as a site to spearhead clinical research on disparities through NCORP. In 2019, Baptist Cancer Center was awarded a second $9 million research grant under NCORP to build a clinical trials infrastructure across the Mid-South. In 2020, Baptist Memorial Health Care launched the Mid-South Miracle, a multifaceted initiative aimed at reducing lung cancer deaths in the Mid-South 25% by 2030. For more information, please visit baptistcancercenter.com, or follow us on Facebook at @baptistcancercenter.
###